硬化骨质对脊柱结核患者的抗结核药物分配产生不利影响:一项前性横截面研究
Guanyin Jiang1,2, Yuchen Tang1,2, Shanlin Xiang1,2
1Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
The Journal of bone and joint surgery. American volume
|February 3, 2025
概括
硬化骨阻碍了脊柱结核病 (STB) 病变中的抗结核药物分配,而非碎片化骨是更大的障碍. 血液中的药物水平与没有硬化骨或有碎片硬化骨的患者的病变水平相关.
科学领域:
- 药理学 药理学是指药理学的学科.
- 整形外科 整形外科 整形外科
- 传染性疾病 传染性疾病
背景情况:
- 研究了硬化骨对抗结核病 (抗结核病) 药物分配的影响.
- 专注于脊柱结核病 (STB) 病变和血液和骨组织中的药物度.
研究的目的:
- 确定硬化骨如何影响STB患者抗结核药物的分配.
- 为了比较结核病病变中的药物度,结核病患者和不结核病患者之间的骨.
主要方法:
- 56名STB患者 (2020-2023) 的前性研究,按CT扫描中的硬化骨的存在划分.
- 在手术期间采集血液和骨样本 (正常的脊椎,STB病变).
- 在采集的样本中,量化了pyrazinamide,rifampicin,isoniazid和ethambutol的度.
主要成果:
- 抗结核病药物水平从血液下降到正常的骨,到结核病变.
- 与没有结核病的患者相比,患有结核病的患者的结核病病变中的药物度明显较低.
- 非碎片性硬化骨在病变中显示的药物水平低于碎片性硬化骨.
- 血和正常骨药物水平在硬化和非硬化组之间是相似的.
- 在非硬化和碎片硬化骨群体中,血液和病变药物水平之间的线性相关性.
结论:
- 结核性骨对STB病变中的抗结核药物传播产生负面影响.
- 非碎片性硬化骨对药物分发的阻碍比碎片性硬化骨更为重要.
- 在没有硬化骨或有碎片硬化骨的STB患者中观察到的血液和病变药物水平之间的线性相关性.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Drug Distribution: Tissue Binding
2.5K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.5K
Pulmonary Tuberculosis IV
132
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
132
Pulmonary Tuberculosis III
299
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
299
Factors Affecting Drug Distribution: Physiological Barriers
159
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
159


